CLINICAL_TRIALS
research
· 2009-10-14
Clinical Trial Update: Brain-derived Neurotrophic Factor Participates in Visceral Hyperalgesia in Irritable Bowel Syndrome (IBS) Patients
Summary
The update discusses a study examining brain-derived neurotrophic factor (BDNF) in visceral hyperalgesia among patients with irritable bowel syndrome (IBS).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Shandong University | Conditions: Irritable Bowel Syndrome | Status: UNKNOWN